Tirzepatide in obesitythe surmount clinical study program The GLP-1RA liraglutide has been approved for the pharmacological treatment of obesity and various other GLP-1RA may be approved in the future for this indication as well (3941, 81)
ImproBiome delivers 1,957 mg of three synergistic prebiotic fibers per serving: PreticX Xylooligosaccharides (XOS), dual-source Inulin from Chicory Root and Jerusalem Artichoke, and Apple Pectin to nourish the beneficial gut bacteria responsible for natural GLP-1 production and support digestive comfort
Clinical trials have shown that discontinuing treatment typically results in gradual weight regain and worsening glycemic control, underscoring that these are chronic disease management tools rather than short-term interventions
Lancet 359 , 824830 (2002)
Future developments affecting us may not be those that we have anticipated
Survey Data: A national survey of 1,827 U.S